Login / Signup

Metabolome Analysis Reveals Excessive Glycolysis via PI3K/AKT/mTOR and RAS/MAPK Signaling in Methotrexate-Resistant Primary CNS Lymphoma-Derived Cells.

Ryuya YamanakaAzusa Hayano
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
These results can help us understand targeted therapies with selective anticancer drugs in recurrent CNS lymphoma-acquired resistance against methotrexate.
Keyphrases